Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Free Cash Flow (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Free Cash Flow readings, the most recent being -$392550.0 for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 8.6% to -$392550.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$184594.0, a 90.19% increase, with the full-year FY2025 number at -$221530.0, up 69.5% from a year prior.
  • Free Cash Flow hit -$392550.0 in Q1 2026 for Pharma-Bio Serv, down from $279316.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.1 million in Q3 2022 to a low of -$700744.0 in Q2 2024.
  • Median Free Cash Flow over the past 5 years was -$78590.0 (2024), compared with a mean of $65669.0.
  • Biggest five-year swings in Free Cash Flow: crashed 179.32% in 2024 and later soared 455.41% in 2025.
  • Pharma-Bio Serv's Free Cash Flow stood at $247954.0 in 2022, then increased by 25.03% to $310016.0 in 2023, then plummeted by 125.35% to -$78590.0 in 2024, then soared by 455.41% to $279316.0 in 2025, then plummeted by 240.54% to -$392550.0 in 2026.
  • The last three reported values for Free Cash Flow were -$392550.0 (Q1 2026), $279316.0 (Q4 2025), and $234488.0 (Q3 2025) per Business Quant data.